Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurovirol ; 8(6): 496-512, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12476345

ABSTRACT

The ability of microglia, the brain's resident macrophage, to present antigen through the class II major histocompatibility complex (MHC) to T cells allows these normally quiescent cells to play a critical role in shaping the outcome of many neurological diseases. The expression of class II MHC antigens and the costimulatory molecules CD40 and B7 on microglia and infiltrating macrophages is regulated through a complex network of cytokines in the inflamed brain. In this review, we describe the molecular mechanisms underlying class II MHC, CD40 and B7 regulation in microglia and macrophages. Our focus is on the cis-elements in the promoters of their genes and the transcription factors activated by cytokines that bind them. The functional implications of aberrant class II MHC, CD40 and B7 expression by microglia and macrophages as related to the diseases of Multiple Sclerosis and Alzheimer's Disease are discussed.


Subject(s)
B7-1 Antigen/immunology , CD40 Antigens/immunology , Central Nervous System Diseases/immunology , Histocompatibility Antigens Class II/immunology , Humans , Macrophages/immunology , Microglia/immunology
2.
J Immunol ; 169(5): 2354-60, 2002 Sep 01.
Article in English | MEDLINE | ID: mdl-12193701

ABSTRACT

CD40 is a type I membrane-bound molecule belonging to the TNFR superfamily that is expressed on various immune cells including macrophages and microglia. The aberrant expression of CD40 is involved in the initiation and maintenance of various human diseases including multiple sclerosis, arthritis, atherosclerosis, and Alzheimer's disease. Inhibition of CD40 signaling has been shown to provide a significant beneficial effect in a number of animal models of human diseases including the aforementioned examples. We have previously shown that IFN-gamma induces CD40 expression in macrophages and microglia. IFN-gamma leads to STAT-1alpha activation directly and up-regulation of NF-kappaB activity due to the secretion and subsequent autocrine signaling of TNF-alpha. However, TNF-alpha alone is not capable of inducing CD40 expression in these cells. Suppressor of cytokine signaling 1 protein (SOCS-1) is a cytokine-inducible Src homology 2-containing protein that regulates cytokine receptor signaling by inhibiting STAT-1alpha activation via a specific interaction with activated Janus kinase 2. Given the important role of CD40 in inflammatory events in the CNS as well as other organ systems, it is imperative to understand the molecular mechanisms contributing to both CD40 induction and repression. We show that ectopic expression of SOCS-1 abrogates IFN-gamma-induced CD40 protein expression, mRNA levels, and promoter activity. Additionally, IFN-gamma-induced TNF-alpha secretion, as well as STAT-1alpha and NF-kappaB activation, are inhibited in the presence of SOCS-1. We conclude that SOCS-1 inhibits cytokine-induced CD40 expression by blocking IFN-gamma-mediated STAT-1alpha activation, which also then results in suppression of IFN-gamma-induced TNF-alpha secretion and subsequent NF-kappaB activation.


Subject(s)
CD40 Antigens/biosynthesis , CD40 Antigens/genetics , Carrier Proteins/physiology , Cytokines/antagonists & inhibitors , Cytokines/physiology , Immunosuppressive Agents/pharmacology , Macrophages/immunology , Macrophages/metabolism , Repressor Proteins , Animals , Antigens, CD/genetics , Antigens, CD/physiology , Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Cell Line , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/metabolism , Down-Regulation/genetics , Down-Regulation/immunology , Interferon-Stimulated Gene Factor 3 , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/physiology , Mice , NF-kappa B/antagonists & inhibitors , NF-kappa B/metabolism , Promoter Regions, Genetic/immunology , Proteins/antagonists & inhibitors , Proteins/genetics , Proteins/metabolism , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/biosynthesis , Receptor-Interacting Protein Serine-Threonine Kinases , Receptors, Tumor Necrosis Factor/antagonists & inhibitors , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/physiology , Receptors, Tumor Necrosis Factor, Type I , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling Proteins , Transcription Factors/antagonists & inhibitors , Transcription Factors/metabolism , Transfection , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Tumor Necrosis Factor-alpha/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...